STEM CELLS AND PANCREATIC CELLS WHICH CAN BE USED FOR THE TREATMENT OF INSULIN-DEPENDENT DIABETES MELLITUS

摘要

Fresh human pancreas tissue can be used as a source of cells whence to identify and select a non-stem cell population that is predisposed to be a source for surrogate pancreatic cells that can be used in treating insulin-dependent diabetes. The progenitors of these surrogate pancreatic cells have no reprogramming genes integrated into their genomes, differentiate to the pancreatic lineage pursuant to a protocol that employs only defined reagents, and are substantially unable to differentiate to the mesodermal lineage.